---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-24-002647"
form_type: "8-K"
ticker: "LFWD"
cik: "0001607962"
company_name: "Lifeward Ltd."
filed_at: "2024-08-15T23:59:59+00:00"
generated_at: "2026-05-31T09:00:59.796808+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lifeward Q2 2024 revenue $6.7M (+400% YoY); net loss $0.50/shr, guidance reaffirmed

## Summary
- Revenue of $6.7M, up from $1.3M in Q2 2023; ReWalk historical product revenue rose 131%.
- Net loss of $4.3M ($0.50/shr) vs. $4.6M ($0.55/shr) a year ago; adjusted net loss $3.6M ($0.42/shr).
- Record 20 ReWalk systems placed; Medicare claims from prior quarters beginning to be paid.
- Cash $15.1M with no debt; FY 2024 revenue guidance maintained at $28M-$32M.
- Launched NEO anti-gravity treadmill; FDA submission for 7th-gen ReWalk completed in June.

## SEC filing metadata
- accession: 0001178913-24-002647
- form_type: 8-K
- ticker: LFWD
- cik: 0001607962
- company_name: Lifeward Ltd.
- filed_at: 2024-08-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607962/000117891324002647/0001178913-24-002647-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607962/000117891324002647/zk2431866.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-24-002647
- JSON: https://secwatch.observer/filing/0001178913-24-002647.json
- Plain text: https://secwatch.observer/filing/0001178913-24-002647.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.